Cellular Immunotherapy in Recipients of HLA-matched, Living Donor Kidney Transplants

Clinical trial NCT03363945 · COMPLETED

Trial details

NCT number: NCT03363945
Sponsor: Medeor Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Transplant Rejection

Start date: 2018-03-15
Primary completion: 2024-04-11
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.